Europe is losing the race for new medicines. Ireland now has six months to change course

EU PERSPECTIVES - Europe's share of global clinical trials has been cut in half in just a decade, while China has surged ahead. As Ireland takes over the EU presidency on Wednesday, Dublin is betting that faster drug approvals, biotech reforms and health investment can restore Europe's competitiveness — and determine how quickly patients get access to new medicines. Read more

Irish Health Minister Jennifer Carroll MacNeill takes the baton from her Cypriot counterpart, Neofytos Charalambides / Photo: Council of the European Union